CTAK Demonstration at ASCRS 2023
August 14, 2023
In this recording of the live presentation from ASCRS 2023, Peter S. Hersh, M.D.; Steven A. Greenstein, M.D.; and John P. Berdahl, M.D. showcase CorneaGen’s newest addition to their Sterile Tissue offerings, Corneal Tissue Addition for Keratoplasty (CTAK). CTAK offers an innovative solution for keratoconic eyes with advanced corneal contouring using patient-specific laser-cut tissue segments. These tissue are gamma-irradiated for sterility and stability, providing enhanced vision, comfort, and the opportunity to regain sight while honoring the gift of donation.
Recent Articles
-
Bernie’s Quartely – November 2023
A message from Bernie Iliakis, President & CEO of CorneaGen...
READ MORE -
Annie Thompson Recognized by Fabulous Washington
Our very own CFO, Annie Thompson, has been profiled in...
READ MORE -
Bernie’s Quarterly Update – June 2023
We’re halfway through 2023 and happy about how things are...
READ MORE -
CorneaGen Recognized With Cigna Healthy Workforce Designation
Cigna has selected CorneaGen as a recipient of their Bronze...
READ MORE